A-T Parents,

While we are not aware of anyone with A-T in the world who has contracted COVID-19, the situation in our communities definitely impacts A-T families as they stay home to keep safe.

To help families navigate this new normal, the A-T Children’s Project hosted a special webinar on Tuesday April 28th:

COVID-19 and Ataxia-Telangiectasia – a conversation with:

  • Howard Lederman, MD, PhD – Pediatric Immunologist and Director of the A-T Clinical Center at Johns Hopkins Children’s Center
  • Brad Margus – Co-Founder of the A-T Children’s Project

Watch the replay on our YouTube channel: https://www.youtube.com/watch?v=nBUwHaD8nCw 

We hope this helps!

Please take care,


Jennifer Thornton, Executive Director

Related News

May 23 @ 7:25 am

Shining a Light on A-T at the IlluminATion Ball

The A-TCP is hosting IlluminATion: A BioPharma Leadership Ball on May 11 in Boston to shine a light

May 23 @ 7:25 am

NEAT Study – Phase 3 Clinical Trial of EryDex, a Low-Dose Steroid

Quince Therapeutics is advancing a phase 3 clinical trial to evaluate EryDex, a potential new treatment for ataxia-telangiectasia

May 23 @ 7:25 am

Measles Prevention in A-T: Recommendations from Dr. Lederman

Dr. Lederman of the A-T Clinical Center provides recommendations to keep people with A-T from catching measles.

May 23 @ 7:25 am

Looking Forward to Research Advances in 2024

As 2023 is wrapping up, we want to thank all of you who support the A-T Children’s Project